546 related articles for article (PubMed ID: 8242866)
1. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
2. Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoylphorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice.
Ward JM; Rehm S; Devor D; Hennings H; Wenk ML
Environ Health Perspect; 1986 Sep; 68():61-8. PubMed ID: 3096710
[TBL] [Abstract][Full Text] [Related]
3. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
5. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
6. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
8. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Katiyar SK; Mohan RR; Agarwal R; Mukhtar H
Carcinogenesis; 1997 Mar; 18(3):497-502. PubMed ID: 9067548
[TBL] [Abstract][Full Text] [Related]
9. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
11. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
12. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
Nesnow S; Bergman H; Slaga TJ
Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
[TBL] [Abstract][Full Text] [Related]
14. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
15. Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice.
Hennings H; Spangler EF; Shores R; Mitchell P; Devor D; Shamsuddin AK; Elgjo KM; Yuspa SH
Environ Health Perspect; 1986 Sep; 68():69-74. PubMed ID: 3780634
[TBL] [Abstract][Full Text] [Related]
16. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.
Niwa Y; Terashima T; Sumi H
Br J Dermatol; 2003 Nov; 149(5):960-7. PubMed ID: 14632799
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
Reiners JJ; Pavone A; Rupp T; Cantu AR
Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
[TBL] [Abstract][Full Text] [Related]
20. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH
Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]